Artiva Biotherapeutics CEO Fred Aslan sells $168,875 in common stock

ARTV•2026-10-07

CEO Fred Aslan sold 23,463 Artiva Biotherapeutics common shares on Oct. 6, 2026, at a weighted average price of $7.1977 per share, leaving him with 1,519,606 shares.

1. Share sale details

Aslan sold 23,463 common shares on Oct. 6, 2026, for a weighted average price of $7.1977 per share. His direct holdings fell to 1,519,606 shares after the transaction.

Sources

Artiva Biotherapeutics CEO Fred Aslan sells $168,875 in common stock

Sec

Artiva Biotherapeutics CEO Fred Aslan sells $168,875 in common stock

1. Share sale details

Related News

W&T Offshore converts $50 million revolver into reserve-based lending facility

VeriSign CEO D. James Bidzos sells $962,349 in common shares

Stoneridge names Vivek Anand VP, commercial strategy and global sales

Sources

Artiva Biotherapeutics CEO Fred Aslan sells $168,875 in common stock

Liquidia director Stephen M. Bloch sells 235,477 shares worth $6.39 million

Sterling Infrastructure General Counsel, CCO Katherine Hargis files initial beneficial ownership statement